David J. Goldberg
Distinguished in Hypoplastic Left Heart Syndrome (HLHS)

Dr. David J. Goldberg

Pediatric Cardiology | Pediatrics
3401 Civic Center Blvd, Children's Hospital Of Philadelphia - Cardiology, 
Philadelphia, PA 
Distinguished in Hypoplastic Left Heart Syndrome (HLHS)
3401 Civic Center Blvd, Children's Hospital Of Philadelphia - Cardiology, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

David Goldberg is a Pediatric Cardiologist and a Pediatrics provider in Philadelphia, Pennsylvania. Dr. Goldberg is rated as a Distinguished provider by MediFind in the treatment of Hypoplastic Left Heart Syndrome (HLHS). His top areas of expertise are Hypoplastic Left Heart Syndrome (HLHS), Pulmonary Atresia with Intact Ventricular Septum, Pulmonary Atresia, Heart Transplant, and Percutaneous Coronary Intervention (PCI).

His clinical research consists of co-authoring 560 peer reviewed articles and participating in 13 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 16 articles in the study of Hypoplastic Left Heart Syndrome (HLHS).

Specialties
Pediatric Cardiology
Pediatrics
Licenses
Pediatrics in PA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Geisinger
  • HMO
  • POS
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

3401 Civic Center Blvd, Children's Hospital Of Philadelphia - Cardiology, Philadelphia, PA 19104

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

13 Clinical Trials

A Trial of Transplanting Hepatitis C Kidneys Into Hepatitis C-Negative Kidney Recipients
A Trial of Transplanting Hepatitis C Kidneys Into Hepatitis C-Negative Kidney Recipients
Enrollment Status: Active_not_recruiting
Publish Date: October 08, 2025
Intervention Type: Drug
Study Drug: Epclusa
Study Phase: Phase 2
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: August 03, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Prospective Blinded Within-Subject Randomized Controlled Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions
A Prospective Blinded Within-Subject Randomized Controlled Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions
Enrollment Status: Completed
Publish Date: May 24, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Phase 2, Multi-Center, Randomized, Multiple Arm, Controlled Pilot Study to Evaluate the Safety and Efficacy of Various Doses of STP705 in Reducing Post- Keloidectomy Keloid Recurrence
A Phase 2, Multi-Center, Randomized, Multiple Arm, Controlled Pilot Study to Evaluate the Safety and Efficacy of Various Doses of STP705 in Reducing Post- Keloidectomy Keloid Recurrence
Enrollment Status: Completed
Publish Date: March 19, 2024
Intervention Type: Drug, Other
Study Drug: STP705
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intralesional Injection of STP705 in Adult Patients With Cutaneous Squamous Cell Carcinoma in Situ (isSCC)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intralesional Injection of STP705 in Adult Patients With Cutaneous Squamous Cell Carcinoma in Situ (isSCC)
Enrollment Status: Completed
Publish Date: March 18, 2024
Intervention Type: Drug, Other
Study Drug: STP705
Study Phase: Phase 2
Safety and Efficacy of Sofwave Treatment for Acne Scars Appearance Improvement
Safety and Efficacy of Sofwave Treatment for Acne Scars Appearance Improvement
Enrollment Status: Completed
Publish Date: November 18, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-to-Severe Atopic Dermatitis
A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: October 17, 2023
Intervention Type: Drug
Study Drug: Lebrikizumab
Study Phase: Phase 3
Open-Labeled Trial Of Direct-Acting Antiviral Treatment Of Hepatitis C-Negative Patients Who Receive Kidney Transplants From Hepatitis C-Positive Donors
Open-Labeled Trial Of Direct-Acting Antiviral Treatment Of Hepatitis C-Negative Patients Who Receive Kidney Transplants From Hepatitis C-Positive Donors
Enrollment Status: Completed
Publish Date: June 15, 2023
Intervention Type: Drug
Study Drugs: Zepatier, Mavyret
Study Phase: Phase 1/Phase 2
A Multicenter, Randomized, Double Blind, Vehicle-controlled, Phase 2 Efficacy and Safety Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Patients With Non-Gorlin High Frequency BCC
A Multicenter, Randomized, Double Blind, Vehicle-controlled, Phase 2 Efficacy and Safety Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Patients With Non-Gorlin High Frequency BCC
Enrollment Status: Terminated
Publish Date: May 31, 2023
Intervention Type: Drug
Study Drug: Patidegib
Study Phase: Phase 2
Safety and Efficacy of Sofwave Treatment to Lift Lax Skin
Safety and Efficacy of Sofwave Treatment to Lift Lax Skin
Enrollment Status: Completed
Publish Date: October 26, 2022
Intervention Type: Device
Study Phase: Phase 3
Simultaneous Application of High-Intensity Focused Electromagnetic Procedure and Radiofrequency for Toning of Buttocks
Simultaneous Application of High-Intensity Focused Electromagnetic Procedure and Radiofrequency for Toning of Buttocks
Enrollment Status: Completed
Publish Date: February 09, 2022
Intervention Type: Device
Study Phase: Not Applicable
Pilot Study to Evaluate VelaShape III & UltraShape Power Combined Treatment for Thigh Circumference Reduction
Pilot Study to Evaluate VelaShape III & UltraShape Power Combined Treatment for Thigh Circumference Reduction
Enrollment Status: Completed
Publish Date: January 09, 2020
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of the Efficacy and Safety of the PiQo4 Picosecond Laser (PSL) System for the Treatment of Patients With Melasma: A Prospective, Randomized, Split Face Study Comparing the Added Value of 585nm Over 1064nm PSL
Evaluation of the Efficacy and Safety of the PiQo4 Picosecond Laser (PSL) System for the Treatment of Patients With Melasma: A Prospective, Randomized, Split Face Study Comparing the Added Value of 585nm Over 1064nm PSL
Enrollment Status: Completed
Publish Date: December 27, 2019
Intervention Type: Device
Study Phase: Not Applicable
View 12 Less Clinical Trials

560 Total Publications

Epidemiology of Colon Cancer Screening in a Safety-Net Setting.
Epidemiology of Colon Cancer Screening in a Safety-Net Setting.
Journal: AJPM focus
Published: October 06, 2025
Similar Doctors
Elite in Hypoplastic Left Heart Syndrome (HLHS)
Dr. Chitra Ravishankar
Pediatric Cardiology | Intensive Care Medicine | Pediatrics
Elite in Hypoplastic Left Heart Syndrome (HLHS)
Dr. Chitra Ravishankar
Pediatric Cardiology | Intensive Care Medicine | Pediatrics

Childrens Health Care Associates Inc

3401 Civic Ctr Blvd, 
Philadelphia, PA 
 (0.1 miles away)
215-590-1000
Languages Spoken:
English
See accepted insurances

Chitra Ravishankar is a Pediatric Cardiologist and an Intensive Care Medicine provider in Philadelphia, Pennsylvania. Dr. Ravishankar is rated as a Distinguished provider by MediFind in the treatment of Hypoplastic Left Heart Syndrome (HLHS). Her top areas of expertise are Hypoplastic Left Heart Syndrome (HLHS), Congenital Heart Disease (CHD), Tetralogy of Fallot, Heart Transplant, and Gastrostomy.

Elite in Hypoplastic Left Heart Syndrome (HLHS)
Dr. Jack R. Rychik
Pediatric Cardiology | Cardiology | Pediatrics
Elite in Hypoplastic Left Heart Syndrome (HLHS)
Dr. Jack R. Rychik
Pediatric Cardiology | Cardiology | Pediatrics
3401 Civic Center Blvd, Children's Hospital Of Philadelphia - Cardiology, 
Philadelphia, PA 
 (0.1 miles away)
215-590-4040
Languages Spoken:
English
See accepted insurances

Jack Rychik is a Pediatric Cardiologist and a Cardiologist in Philadelphia, Pennsylvania. Dr. Rychik is rated as a Distinguished provider by MediFind in the treatment of Hypoplastic Left Heart Syndrome (HLHS). His top areas of expertise are Hypoplastic Left Heart Syndrome (HLHS), Congenital Heart Disease (CHD), Lymphangiectasis, Congenital Pulmonary Lymphangiectasia, and Heart Transplant.

Distinguished in Hypoplastic Left Heart Syndrome (HLHS)
Dr. Jonathan J. Rome
Pediatric Cardiology | Pediatrics
Distinguished in Hypoplastic Left Heart Syndrome (HLHS)
Dr. Jonathan J. Rome
Pediatric Cardiology | Pediatrics
3401 Civic Center Blvd, Children's Hospital Of Philadelphia - Cardiology, 
Philadelphia, PA 
 (0.1 miles away)
215-590-4040
Languages Spoken:
English
See accepted insurances

Jonathan Rome is a Pediatric Cardiologist and a Pediatrics provider in Philadelphia, Pennsylvania. Dr. Rome is rated as a Distinguished provider by MediFind in the treatment of Hypoplastic Left Heart Syndrome (HLHS). His top areas of expertise are Congenital Heart Disease (CHD), Hypoplastic Left Heart Syndrome (HLHS), Pulmonary Vein Stenosis, Angioplasty, and Heart Transplant.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Goldberg's expertise for a condition
ConditionClose
    View All 36 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile